TQS sets a High Bar in Serialisation and Aggregation Lines at Boehringer Ingelheim
Автор: WIPOTEC GmbH
Загружено: 2021-04-26
Просмотров: 1166
As one of the world’s 20 leading pharmaceutical companies, the Boehringer Ingelheim group operates globally with 175 affiliates and employs more than 51,000 professionals. Since it exports pharmaceuticals to different markets worldwide, implementing all necessary anti-counterfeiting measures and complying with serialisation and anti-tampering requirements of different countries is an absolut prerequisite on the company’s agenda. As part of its large-scale compliance project, the pharmaceutical company equipped its production lines with vstate-of-the-art serialisation and aggregation technology from WIPOTEC-OCS. Boehringer Ingelheim’s strategic investment has led to a successful implementation and assuring the reliable anti-counterfeit protection combined with serialisation of pharmaceutical products and thereby meeting the ultimate goal of enhancing patient health and safety.
Visit the Wipotec website: https://www.wipotec-ocs.com/en/
Check out our media center: https://www.wipotec-ocs.com/en/media-...
Find Wipotec on LinkedIn: / wipotec-ocs
Доступные форматы для скачивания:
Скачать видео mp4
-
Информация по загрузке:
